FDA Issues Draft Guidance onAIUse in Medical Products - The National Law Review
FDA issues draft guidances on AI in drugs, biologics, and medical devices. Learn about the new recommendations and submission processes for …
Read the original at The National Law Review ↗
- Topics
- HealthcareRegulation & Policy
- Mentions
- FDA
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”